Efficacy and Safety of Bromfenac Ophthalmic Solution

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

This is a safety and efficacy study of bromfenac ophthalmic solution

• Phase: Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Bausch & Lomb Incorporated
• Treatments: Bromfenac; Ophthalmic Solutions; Pharmaceutical Solutions

Criteria

Inclusion Criteria:

• Male or female greater than or equal to 18 years of age, and scheduled for cataract surgery

Exclusion Criteria:

• Active corneal pathology in either eye